Clinical trial
The Effects of L-arabinose on Intestinal Sucrase Activity in Man
NCT00302302 · University of Copenhagen, Other · Completed
Key facts
| NCT number | NCT00302302 |
|---|---|
| Title | The Effects of L-arabinose on Intestinal Sucrase Activity in Man |
| Official title | The Effects of Increasing Doses of L-arabinose in a Sucrose Rich Meal on Intestinal Sucrase Activity in Man |
| Lead sponsor | University of Copenhagen, Other |
| Collaborators | Danisco Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Blood Glucose |
| Intervention type | Drug |
| Interventions | L-arabinose |
| Enrollment | 15 |
| Start date | Sep 1, 2005 |
| Primary completion | Nov 1, 2005 |
| Completion | Jan 1, 2006 |
| First posted | Mar 14, 2006 |
| Last update posted | Feb 26, 2014 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: